RxDoctor Payments Data

Kathleen Ouellette

Physician Assistant · Stamford, CTNPI 1194351056

Payments from drug & device makers

$3,653in general payments, 2019–2025

Across 177 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$881
  • EMD Serono, Inc.$452
  • SK Life Science, Inc.$433
  • Lilly USA, LLC$229
  • Harmony Biosciences LLC$215
  • Neurocrine Biosciences, Inc.$149
  • plus $1K from 26 others

What the payments were for

  • Speaking & faculty fees$251%
  • Food & beverage$3,62599%
  • Education$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,653 in reported general payments places this provider in the 90th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Most prescribed under Part D

DrugClaimsCost to plans & patients
VumerityDiroximel Fumarate23$192,560
Nurtec OdtRimegepant Sulfate40$66,537
UbrelvyUbrogepant38$53,753
RexultiBrexpiprazole19$32,649
QuliptaAtogepant22$25,429
Emgality PenGalcanezumab-Gnlm19$18,589
NamzaricMemantine Hcl/Donepezil Hcl16$8,856
Memantine Hcl ErMemantine Hcl56$6,059
Pregabalin121$3,861
Levetiracetam124$2,743
Lidocaine42$2,622
Duloxetine Hcl100$2,522
Rivastigmine17$2,452
Lacosamide29$2,399
Doxepin Hcl12$2,203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BiogenVumerity$46$192,56023 claims
AbbVieUbrelvy, Qulipta, Namzaric$881$88,03776 claims
PfizerNurtec Odt$138$66,53740 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →